The price of this share is at 2,47$, In this post we are going to talk about the listed company Oramed Pharmaceuticals Inc, its leaders are David Silberman (Chief Financial Officer, Secretary & Treasurer), Joshua Hexter (Chief Operating & Business Officer), Miriam Kidron (Director & Chief Scientific Officer), Nadav Kidron (President, Chief Executive Officer & Director), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the Middle East region.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 2,31$ - 2,48$, with a percentage difference of 2,40$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
